Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ12111213-0,33
KB10331035-0,29
PKN83,883,84-0,80
Msft1,58
Nokia4,3834,386-0,36
IBM1,50
Mercedes-Benz Group AG49,8249,835-0,51
PFE0,24
07.07.2025 9:28:53
Indexy online
AD Index online
select
AD Index online
 

  • 03.07.2025 23:04:00
cbdMD Rg (NY Consolidated)
Závěr k 3.7.2025 Změna (%) Změna (USD) Objem obchodů (ks)
0,86 -6,40 -0,06 29 120
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 07.07.2025
Popis společnosti
Obecné informace
Název společnosticbdMD Inc
TickerYCBD
Kmenové akcie:Ordinary Shares
RICYCBD.K
ISIN-
Prioritní akciePreferred Shares Series A
RICYCBD_pa.A^E25
Poslední známé roční výsledky30.09.2024
Poslední známé čtvrtletní výsledky31.03.2025
Počet zaměstnanců k 01.12.2024 42
Akcie v oběhu k 15.05.2025 8 908 406
MěnaUSD
Kontaktní informace
Ulice8845 Red Oak Blvd
MěstoCHARLOTTE
PSČ28217-5593
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon17 044 453 060

Business Summary: cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Financial Summary: BRIEF: For the six months ended 31 March 2025, cbdMD Inc revenues increased 1% to $9.9M. Net loss applicable to common stockholders decreased 59% to $2.5M. Revenues reflect Wholesale sales segment increase of 34% to $2.3M. Lower net loss reflects Decrease (increase) in fair value of con increase from $1.4M (expense) to $87K (income), All other expenses decrease of 68% to $439K (expense).
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICS2007Medicinal & Botanical Mfg
NAICS2007Toilet Preparation Manufacturing
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Toilet Preparation Manufacturing
SICMedicinals And Botanicals



  • Poslední aktualizace: 07.07.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Chief Financial Officer, DirectorT. Ronan Kennedy4619.12.2024
Chief Accounting Officer, Treasurer, Company SecretaryBradley Whitford43
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, DirectorSibyl Swift44